Chemotherapy in Very Elderly Men with Metastatic Castration-Resistant Prostate Cancer

Clinical trials for treatment of men with advanced prostate cancer often don’t include men who are considered very elderly (aged over 80 years). So, even if we know that a treatment is tolerable and effective in the average man, we can not assume that it would also be in the very elderly, especially in reference [...]

Perioperative Complications following Artificial Urinary Sphincter Placement After Prostate Cancer Surgery

Urinary incontinence post-prostatectomy is a too common complaint from men. Although the actual degree of incontinence suffered ranges from being minor, or a simple and small amount of post urination dribble, to a complete and total inability to control any urine flow, the most bothersome issues that significantly affects a man’s quality of life (QoL) [...]

Role of Anxiety Reduction in Men with a Prostate Cancer Recurrence

Increasingly, we have become better informed about the possible role of psychological and spiritual interventions in the treatment of cancer, specifically for this post in men with locally advanced prostate cancer. This post is limited to just discussing the possible interventions specifically in men with a Biochemical Prostate Cancer Recurrence, commonly referred to as a [...]

Xofigo Without A Co-Pay For Men Who Are Uninsured or Who Have A Medical Policy That Doesn’t Cover Xofigo

I have been informed that it is now possible for men in need of the treatment Xofigo to obtain it without having to pay any co-pays.  The program that is making this possible is called Xofigo Access Services and is designed to make Xofigo available for men with a commercial medical insurance policy (not medicaid [...]

NCI Opens New Trial – Understanding Genetic Similarities In Different Cancers

The National Cancer Institute (NCI) announced a new trial to evaluate genetic similarities in a variety of cancer types. I think that this is a great trial, which those of us who might qualify for it should think about participating. Increasingly we are thinking that to define (name) a cancer just upon the affected body [...]

Increased Risks for Cardiovascular Events in Men with Prostate Cancer on GnRH Agonist Therapy

Traditional hormone therapy usually consists of two types of drugs; GnRH agonists (like Lupron and Zoladex) and antiandrogens (Casodex). Although they both are drugs that manipulate the hormone system their modes of action are different. GnRH agonists block the production of the male hormone testosterone while the antiandrogen drug blocks the ability of the prostate [...]

Advanced Prostate Cancer Survey Closing Soon…Go to www.prostatecancersurvey.org

My Prostate Cancer Experience is a new survey, helping us understand how prostate cancer treatment affects day to day living. The Prostate Cancer Experience encompasses all of the prostate cancer treatments that you may have chosen.  The survey closes in a few days, so please complete it, now. Go to http://prostatecancersurvey.org    My Prostate Cancer Experience takes less [...]

By |2020-02-04T11:56:25-05:00August 10th, 2015|Advanced Prostate Cancer, Uncategorized|0 Comments

The Need To Expand Research Into Pre-hab Therapy Prior To Cancer Treatment

There is a lot of evidence that pre-treatment rehabilitation (prehabilitation or pre-hab) both speeds up and benefits a patient’s recovery after surgical orthopedic treatment for knee and hip replacement as well as cardiac conditions. Having pre-hab, which is often covered by insurance after orthopedic surgery, is pretty standard. Now, based on an article published in [...]

Long-Term Survival And Good QOL Is Possible in Prostate Cancer With Bone Mets

The development of bone metastases is often been viewed as having significant negative implications for long term survival in men with metastatic castrate resistant prostate cancer (mCRPC). It is generally believed that bone metastases prognosticates a negative impact on both their quality of life and on survival. Contradicting this commonly held belief has been some [...]

Remembering Andrew And Learning From A 28 Year Old Wise Man

Yesterday, my younger son Max, who is 28 years old, went to the funeral of a fraternity brother. Actually, the young man, Andrew, had been a member of his pledge class at the University of Michigan. Andrew, who was also 28 years old, died of Pediatric Brain Cancer.  Andrew had battled this disease for over [...]

Go to Top